Latest Commercialization News

Axel REE has more than doubled the Woolrich resource to 264.6 million tonnes and delivered its first Indicated classification at the Brazilian rare earths project. The upgrade comes as the loss-making explorer prepares a controlled in-situ recovery field validation program, with A$5.73 million in cash at year-end.

Pure One Corporation Limited (ASX:P1E) reported FY26 net profit after tax of A$5.070 million, alongside A$7.191 million in cash and term deposits. The company is positioning battery-swappable heavy vehicles and electric vans as its growth engine, while retaining sizeable interests in gas and clean-energy ventures.

1414 Degrees reported a wider FY2026 loss, falling cash reserves and a material uncertainty over its ability to continue as a going concern. The company is nevertheless pressing ahead with SiNTL battery commercialisation, a proposed 1 GW data centre precinct and full ownership of Aurora.

Yancoal Australia has secured NSW approval to continue mining at Hunter Valley Operations until the end of 2045, clearing a major regulatory hurdle after a six-year process. Federal environmental approval remains outstanding, with a deadline of 31 December 2026.

Javelin Minerals is pursuing an all-scrip takeover by FirstAU after its planned Eureka production partnership with MEGA Resources was terminated over regional processing constraints. The company reported a $2.69 million FY2026 loss, $3.92 million in cash and an auditor warning that further funding is required.

Vection Technologies delivered its first positive full-year operating cash flow and a sharp rise in adjusted EBITDA in FY26. Yet the audited report warns that continued operations depend on stronger sales, margin gains, cost reductions and potential access to further capital.

Venari Minerals has moved Red Mountain from grassroots discovery to a 3.03Mt lithium carbonate equivalent inferred resource, backed by 99.5% battery-grade lithium carbonate test work. The next test is commercial rather than geological, with drilling, permitting and a planned Scoping Study now competing against a large loss and ongoing funding needs.

H3 Energy has consolidated ownership of its Alinya hydrogen and helium project and reframed Warro as a potential commercial gas development, but its annual report warns that funding remains critical. The company ended FY2026 with A$900,434 in cash, net liabilities of A$551,671 and a material uncertainty over its ability to continue as a going concern.

Vitrafy has added US blood network Versiti to its cryopreservation development programme, with the partnership focused on no-wash platelet preservation and regulatory verification. The deal strengthens the company’s institutional network, but initially generates no revenue and remains subject to US regulatory requirements.

Energy Technologies has reported a deeper FY2026 loss, collapsing revenue and a $22.65 million equity deficiency, with its auditor flagging material uncertainty over the group’s ability to continue as a going concern. A five-year laser optics licence offers a potential new revenue path, but it remains conditional on development and future commercial sales.

Iperion reported a lower loss for the year ended 31 March 2026, but its cash reserves and net assets fell sharply, leaving the NZX-listed materials company reliant on related-party funding and director support. Its Pathoglaze manufacturing operation is also being moved from Malaysia to Singapore while customer trials continue.

Compumedics Limited (ASX:CMP) returned to profit in FY26 as record revenue, stronger cash generation and a sharp rise in MEG and SaaS sales reshaped its earnings profile. The company enters FY27 with A$28.3 million of open orders, but lower gross margins and uneven US and European execution remain key tests.